Mirion Technologies CFO Sells 8,400 Shares in Open Market Transaction
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 2 days ago
0mins
Source: Fool
- Insider Trading: On May 7, Mirion Technologies' Chief Accounting Officer Christopher A. Moore sold 8,400 shares of common stock at $19.64 each, totaling $165,000, indicating a potential shift in his confidence regarding the company's stock.
- Historical Comparison: This sale marks Moore's largest direct transaction to date, surpassing his previous sales of 8,153 and 3,430 shares, suggesting a pattern of gradual reduction in his holdings, likely for personal financial management reasons.
- Equity Impact: The transaction affected 27.49% of Moore's direct common stock holdings, leaving him with 22,157 shares, approximately 0.01% of the total shares outstanding, indicating he still retains a meaningful stake in the company.
- Market Outlook: While Moore's sale may raise concerns among investors, Mirion's growth potential in the nuclear energy and radiation safety markets remains attractive; however, analysts caution that current stock prices may already reflect this optimism, urging investors to assess risks carefully.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy MIR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on MIR
Wall Street analysts forecast MIR stock price to rise
6 Analyst Rating
5 Buy
1 Hold
0 Sell
Strong Buy
Current: 17.100
Low
29.00
Averages
30.60
High
34.00
Current: 17.100
Low
29.00
Averages
30.60
High
34.00
About MIR
Mirion Technologies, Inc. is a global provider of radiation detection, measurement, analysis, and monitoring solutions to the nuclear, medical, defense, and research end markets. The Company's segments include Medical, and Nuclear & Safety. The Medical segment includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is in Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety segment includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For nuclear power plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Mirion Technologies CFO Sells 8,400 Shares in Open Market Transaction
- Insider Trading: On May 7, Mirion Technologies' Chief Accounting Officer Christopher A. Moore sold 8,400 shares of common stock at $19.64 each, totaling $165,000, indicating a potential shift in his confidence regarding the company's stock.
- Historical Comparison: This sale marks Moore's largest direct transaction to date, surpassing his previous sales of 8,153 and 3,430 shares, suggesting a pattern of gradual reduction in his holdings, likely for personal financial management reasons.
- Equity Impact: The transaction affected 27.49% of Moore's direct common stock holdings, leaving him with 22,157 shares, approximately 0.01% of the total shares outstanding, indicating he still retains a meaningful stake in the company.
- Market Outlook: While Moore's sale may raise concerns among investors, Mirion's growth potential in the nuclear energy and radiation safety markets remains attractive; however, analysts caution that current stock prices may already reflect this optimism, urging investors to assess risks carefully.
See More
Mirion Technologies Executive Sells 8,400 Shares
- Insider Share Sale: Christopher A. Moore, Chief Accounting Officer of Mirion Technologies, sold 8,400 shares on May 7, 2026, for approximately $165,000 at a price of $19.64 per share, representing 27.49% of his direct holdings and reducing his ownership to 22,157 shares, or about 0.01% of outstanding shares.
- Stable Ownership Structure: Following the transaction, Moore retains 22,157 shares directly, consistent with historical trends of reducing holdings, and all shares involved were directly held, with no impact on indirect holdings, which remain at zero.
- Market Reaction Cautious: While insider sales can cause investor anxiety, analysts note that Mirion's growth potential in the nuclear energy and radiation safety markets remains strong, driven by infrastructure modernization and nuclear expansion, although current share prices may already reflect this optimism.
- Investor Focus: Despite solid revenue growth, Mirion's earnings performance has been uneven, leading to stock volatility; risk-averse investors might prefer diversified ETFs like VanEck Uranium and Nuclear ETF for broader exposure to the industry while mitigating company-specific risks.
See More
Nicholas Investment Partners Sells Shares of Mirion Technologies
- Share Reduction Details: Nicholas Investment Partners disclosed in an SEC filing that it sold 592,382 shares of Mirion Technologies in Q1 2026, valued at approximately $13.36 million, indicating a cautious outlook on the company's future performance.
- Holding Value Decline: As of March 31, the value of Mirion's holdings fell by $14.11 million to $916,078, reflecting market concerns over its stock price, which may impact investor confidence.
- Performance Metrics: Mirion Technologies reported a 27.5% year-over-year revenue increase to $257.6 million in the latest quarter, with orders surging 42%, indicating accelerating growth in the nuclear sector, although it posted a GAAP net loss of $3.4 million, raising concerns about profitability.
- Market Outlook: Despite profitability challenges, Mirion Technologies has potential growth opportunities driven by increased nuclear infrastructure spending and rising demand for radiation monitoring systems, suggesting it may be positioned for a larger growth trajectory in the future.
See More
Mirion Technologies Q1 2026 Earnings Highlights
- Significant Order Growth: Mirion Technologies reported a 42% increase in orders for Q1 2026, reaching $288 million, with a 19% rise to $241 million excluding M&A, indicating strong demand in the nuclear sector and the company's competitive edge in this market.
- Revenue and Profit Performance: Total revenue for the first quarter was $258 million, up 27.5%, with approximately 21% of this growth attributed to the Paragon acquisition, while adjusted EBITDA stood at $54 million, reflecting the company's profitability during its expansion phase.
- Optimistic Future Outlook: The CFO projected a 15% to 20% increase in orders for Q2 compared to Q1 and reaffirmed the unchanged financial guidance for 2026, despite facing tariff impacts from China, demonstrating management's confidence in future growth.
- Strategic Investments and Market Opportunities: Through the acquisitions of Paragon and Certrec, Mirion has enhanced its product and service offerings, which are expected to drive long-term growth, particularly in the small modular reactor (SMR) market, further solidifying its market position.
See More
Mirion (MIR) Q1 2026 Earnings Call Transcript
See More
Mirion Technologies Q1 Earnings Exceed Expectations
- Earnings Beat: Mirion Technologies reported a Q1 non-GAAP EPS of $0.10, beating expectations by $0.01, indicating strong market performance and boosting investor confidence.
- Significant Revenue Growth: The company achieved Q1 revenue of $257.6 million, a 27.5% year-over-year increase, surpassing market expectations by $12.83 million, reflecting sustained demand in the nuclear and industrial technology sectors.
- 2026 Outlook: Mirion reaffirmed its total revenue growth target for 2026 at 22% to 24%, with organic revenue growth projected between 5% and 7%, demonstrating confidence in future growth and clear strategic planning.
- Adjusted EPS Guidance: The adjusted EPS guidance is set at approximately $0.48 to $0.55, below the consensus of $0.55, primarily due to the impact of a one-time CEO retention grant, indicating strategic considerations in executive incentives.
See More
Mirion Technologies CFO Sells 8,400 Shares in Open Market Transaction
- Insider Trading: On May 7, Mirion Technologies' Chief Accounting Officer Christopher A. Moore sold 8,400 shares of common stock at $19.64 each, totaling $165,000, indicating a potential shift in his confidence regarding the company's stock.
- Historical Comparison: This sale marks Moore's largest direct transaction to date, surpassing his previous sales of 8,153 and 3,430 shares, suggesting a pattern of gradual reduction in his holdings, likely for personal financial management reasons.
- Equity Impact: The transaction affected 27.49% of Moore's direct common stock holdings, leaving him with 22,157 shares, approximately 0.01% of the total shares outstanding, indicating he still retains a meaningful stake in the company.
- Market Outlook: While Moore's sale may raise concerns among investors, Mirion's growth potential in the nuclear energy and radiation safety markets remains attractive; however, analysts caution that current stock prices may already reflect this optimism, urging investors to assess risks carefully.
See More
Mirion Technologies Executive Sells 8,400 Shares
- Insider Share Sale: Christopher A. Moore, Chief Accounting Officer of Mirion Technologies, sold 8,400 shares on May 7, 2026, for approximately $165,000 at a price of $19.64 per share, representing 27.49% of his direct holdings and reducing his ownership to 22,157 shares, or about 0.01% of outstanding shares.
- Stable Ownership Structure: Following the transaction, Moore retains 22,157 shares directly, consistent with historical trends of reducing holdings, and all shares involved were directly held, with no impact on indirect holdings, which remain at zero.
- Market Reaction Cautious: While insider sales can cause investor anxiety, analysts note that Mirion's growth potential in the nuclear energy and radiation safety markets remains strong, driven by infrastructure modernization and nuclear expansion, although current share prices may already reflect this optimism.
- Investor Focus: Despite solid revenue growth, Mirion's earnings performance has been uneven, leading to stock volatility; risk-averse investors might prefer diversified ETFs like VanEck Uranium and Nuclear ETF for broader exposure to the industry while mitigating company-specific risks.
See More
Nicholas Investment Partners Sells Shares of Mirion Technologies
- Share Reduction Details: Nicholas Investment Partners disclosed in an SEC filing that it sold 592,382 shares of Mirion Technologies in Q1 2026, valued at approximately $13.36 million, indicating a cautious outlook on the company's future performance.
- Holding Value Decline: As of March 31, the value of Mirion's holdings fell by $14.11 million to $916,078, reflecting market concerns over its stock price, which may impact investor confidence.
- Performance Metrics: Mirion Technologies reported a 27.5% year-over-year revenue increase to $257.6 million in the latest quarter, with orders surging 42%, indicating accelerating growth in the nuclear sector, although it posted a GAAP net loss of $3.4 million, raising concerns about profitability.
- Market Outlook: Despite profitability challenges, Mirion Technologies has potential growth opportunities driven by increased nuclear infrastructure spending and rising demand for radiation monitoring systems, suggesting it may be positioned for a larger growth trajectory in the future.
See More
Mirion Technologies Q1 2026 Earnings Highlights
- Significant Order Growth: Mirion Technologies reported a 42% increase in orders for Q1 2026, reaching $288 million, with a 19% rise to $241 million excluding M&A, indicating strong demand in the nuclear sector and the company's competitive edge in this market.
- Revenue and Profit Performance: Total revenue for the first quarter was $258 million, up 27.5%, with approximately 21% of this growth attributed to the Paragon acquisition, while adjusted EBITDA stood at $54 million, reflecting the company's profitability during its expansion phase.
- Optimistic Future Outlook: The CFO projected a 15% to 20% increase in orders for Q2 compared to Q1 and reaffirmed the unchanged financial guidance for 2026, despite facing tariff impacts from China, demonstrating management's confidence in future growth.
- Strategic Investments and Market Opportunities: Through the acquisitions of Paragon and Certrec, Mirion has enhanced its product and service offerings, which are expected to drive long-term growth, particularly in the small modular reactor (SMR) market, further solidifying its market position.
See More
Mirion (MIR) Q1 2026 Earnings Call Transcript
See More
Mirion Technologies Q1 Earnings Exceed Expectations
- Earnings Beat: Mirion Technologies reported a Q1 non-GAAP EPS of $0.10, beating expectations by $0.01, indicating strong market performance and boosting investor confidence.
- Significant Revenue Growth: The company achieved Q1 revenue of $257.6 million, a 27.5% year-over-year increase, surpassing market expectations by $12.83 million, reflecting sustained demand in the nuclear and industrial technology sectors.
- 2026 Outlook: Mirion reaffirmed its total revenue growth target for 2026 at 22% to 24%, with organic revenue growth projected between 5% and 7%, demonstrating confidence in future growth and clear strategic planning.
- Adjusted EPS Guidance: The adjusted EPS guidance is set at approximately $0.48 to $0.55, below the consensus of $0.55, primarily due to the impact of a one-time CEO retention grant, indicating strategic considerations in executive incentives.
See More
